
    
      OBJECTIVES:

      Primary

        -  Evaluate the tolerability of genistein when combined with chemotherapy

      Secondary:

        -  Evaluate Response Rate (RR) as measured by the radiologic RECIST criteria

        -  Evaluate Progression Free Survival (PFS)
    
  